title: Postprandial hyperlipidemia in Zucker diabetic fatty fa/fa rats, an animal model of type II diabetes, and its amelioration by acyl-CoA:cholesterol acyltransferase inhibition.
abstract: Postprandial hyperlipidemia (PH) is frequently observed in diabetic patients. We performed an oral fat-loading test in Zucker diabetic fatty (ZDF) fa/fa rats, a model for type II diabetes, to determine whether PH was induced in the rats. Post fat-loading changes in serum cholesterol and triglyceride levels were significantly greater in the fa/fa rats than those seen in their lean littermates and an acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor significantly reduced these levels by 24% and 31%, respectively. Therefore, we confirmed that PH appeared in ZDF fa/fa rats by fat loading and ACAT inhibition may be a potential treatment for PH.
authors: Central Research Laboratories, Fujirebio Inc., Hachioji, Tokyo, Japan. kj-fujinami@fujirebio.co.jp
authors: K
authors: K
authors: Fujinami
authors: K
authors: K
authors: Kojima
authors: K
authors: K
authors: Aragane
authors: J
authors: J
authors: Kusunoki
mesh_terms: D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000235:genetics / Q000378:metabolism*; D004041:Dietary Fats / Q000493:pharmacokinetics; D006949:Hyperlipidemias / Q000097:blood*; D019518:Postprandial Period / Q000502:physiology*; D051381:Rats; D011924:Rats, Zucker; D002785:Sterol O-Acyltransferase / Q000037:antagonists & inhibitors*; D014280:Triglycerides / Q000097:blood
chemical_list: D000924:Anticholesteremic Agents; D001786:Blood Glucose; D004041:Dietary Fats; D014280:Triglycerides; D002784:Cholesterol; D002785:Sterol O-Acyltransferase